Structure-activity relationships for substrates and inhibitors of mammalian liver microsomal carboxylesterases. 1996

T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
College of Pharmacy, Xavier University of Louisiana, New Orleans 70125, USA.

OBJECTIVE Carboxylesterases are important in the detoxification of drugs, pesticides and other xenobiotics. This study was to evaluate a series of substrates and inhibitors for characterizing these enzymes. METHODS A series of novel aliphatic esters and thioesters were used in spectral assays to monitor human, murine and porcine esterases. A series of transition state mimics were evaluated as selective esterase inhibitors. RESULTS Several alpha-alkyl thioacetothioates were found to be approximately 2 to 11-fold superior to commonly used substrates for monitoring carboxylesterase activity. Insertion of a heteroatom in the acid portion of these esters in the beta or gamma position relative to the carbonyl had a dramatic effect on enzyme activity with S or O substituents often improving the kCAT/K(M) ratio of the substrate and N decreasing it. Several alpha,alpha'-bis (2-oxo-3,3,3-trifluoropropylthio)alkanes proved to be potent selective transition state mimics of the esterase activity with IC50's from 10(-5) to 10(-9)M. CONCLUSIONS This library of substrates and inhibitors are useful research tools for characterizing the numerous isozymes of carboxylesterases present in mammalian tissues.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002265 Carboxylic Ester Hydrolases Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion. Carboxylesterases,Ester Hydrolases, Carboxylic,Hydrolases, Carboxylic Ester
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006845 Hydrocarbons, Fluorinated Inert liquid or gaseous halocarbon compounds in which FLUORINE replaces some or all HYDROGEN atoms. Fluorinated Hydrocarbons
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
December 1971, Biochemistry,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
April 1975, Biochemical pharmacology,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
March 1986, Journal of medicinal chemistry,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
December 1987, Molecular pharmacology,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
September 2002, European journal of biochemistry,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
September 2005, Chemical research in toxicology,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
November 2007, Journal of medicinal chemistry,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
June 1996, European journal of pharmacology,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
August 1997, Drug metabolism reviews,
T L Huang, and T Shiotsuki, and T Uematsu, and B Borhan, and Q X Li, and B D Hammock
January 2019, Chinese medicine,
Copied contents to your clipboard!